4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-20-057067
Director sold 33,750 shares at an average $136.68 ($4,612,976)
- Director acquired 33,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hindson Benjamin J. · Director
Table I: Non-derivative
11 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-11-02 | Exercise or conversion : show line 1 in the form | +21,062 | $0.88 | $18,535 | 88,562 | D |
| 2020-11-02 | Sale : show line 2 in the form | −3,328 | $135.36 | $450,467 | 85,234 | D |
| 2020-11-02 | Sale : show line 3 in the form | −13,242 | $136.11 | $1,802,377 | 71,992 | D |
| 2020-11-02 | Sale : show line 4 in the form | −1,940 | $136.98 | $265,739 | 70,052 | D |
| 2020-11-02 | Sale : show line 5 in the form | −1,146 | $138.06 | $158,212 | 68,906 | D |
| 2020-11-02 | Sale : show line 6 in the form | −1,406 | $139.13 | $195,622 | 67,500 | D |
| 2020-11-03 | Exercise or conversion : show line 7 in the form | +12,688 | $0.88 | $11,165 | 80,188 | D |
| 2020-11-03 | Sale : show line 8 in the form | −398 | $135.52 | $53,936 | 79,790 | D |
| Open-market sales · 33,750 sh · avg $136.68 · $4,612,976 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-11-02 | Exercise or conversion : show line 12 in the form Stock Option (right to buy) | −21,062 | $0.88 | 2025-10-27 | 21,062 | 91,438 | D |
| 2020-11-03 | Exercise or conversion : show line 13 in the form Stock Option (right to buy) | −12,688 | $0.88 | 2025-10-27 | 12,688 | 78,750 | D |
Loading xslF345X03/doc4.xml…